Citation Tools
PDFTherapeutics/Prevention
Randomised controlled trial
Clinicians should assess the benefits and risks of using bezlotoxumab for reducing the risk of recurrent Clostridium difficile infection
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Clinicians should assess the benefits and risks of using bezlotoxumab for reducing the risk of recurrent Clostridium difficile infection